Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Lipids in Health and Disease|December 19, 2024
The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver diseaseClément J F Heymann, Anne Linde Mak, Adriaan G Holleboom, et al.
Ebiomedicine|October 23, 2020
Differential DNA methylation in familial hypercholesterolemiaLaurens F Reeskamp, Andrea Venema, Joao P Belo Pereira, et al.
Endocrinology|February 27, 2010
Chronic prednisolone treatment reduces hepatic insulin sensitivity while perturbing the fed-to-fasting transition in miceAnke J Laskewitz, Theo H van Dijk, Vincent W Bloks, et al.
European Journal of Preventive Cardiology|February 6, 2025
The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk studyJordan M Kraaijenhof, Marije J Kerkvliet, Nick S Nurmohamed, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 9, 2005
Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob miceAldo Grefhorst, Theo H van Dijk, Anke Hammer, et al.
The Journal of Biological Chemistry|February 1, 2006
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in miceBertrand Cariou, Kirsten van Harmelen, Daniel Duran-Sandoval, et al.
Journal of the American Heart Association|October 8, 2024
Ursodeoxycholic Acid for Trans Intestinal Cholesterol Excretion Stimulation: A Randomized Placebo Controlled Crossover StudyReindert F Oostveen, Yannick Kaiser, Merel L Hartgers, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 6, 2014
A systems biology approach reveals the physiological origin of hepatic steatosis induced by liver X receptor activationBrenda S Hijmans, Christian A Tiemann, Aldo Grefhorst, et al.
Pageof 7